AbstractWe have used cells infected with the HIV-1 molecular clone HX10 to study the binding of monoclonal antibodies (mAbs)to different epitopes within the extracellular domain of the HIV-1 transmembrane glycoprotein gp41. Gp41 mAb binding to the infected cells at 4° was variable but weaker than the binding of an anti-gp120/V3 loop mAb and increased substantially for three of the gp41 antibodies at 37°. Treatment of the cells with soluble CD4 (sCD4) at 37° increased gp41 mAb binding to epitopes spanning residues 521–663, implying that these regions had probably been masked by gp120, which following interaction with sCD4 had subsequently dissociated from gp41. By contrast, the binding of a mAb to residues 662–667 which form a neutralization...
The high affinity binding site for human immunodeficiency virus (HIV) envelope glycoprotein gp120 re...
The high affinity binding site for human immunodeficiency virus (HIV) envelope glycoprotein gp120 re...
Human immunodeficiency virus (HIV-1) enters target cells by binding its gp120 exterior envelope glyc...
We have used cells infected with the HIV-1 molecular clone HX10 to study the binding of monoclonal a...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
A subset of the neutralizing anti-HIV antibodies recognize epitopes on the envelope protein gp120 of...
AbstractUsing immunobiochemical approaches we previously studied the conformation and surface exposu...
AbstractHuman immunodeficiency virus (HIV-1) enters target cells by binding its gp120 exterior envel...
AbstractUsing immunobiochemical approaches we previously studied the conformation and surface exposu...
Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by exper...
AbstractThe binding of antibodies to the CD4-binding site (CD4bs) of the HIV-1 envelope glycoprotein...
Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by exper...
The high affinity binding site for human immunodeficiency virus (HIV) envelope glycoprotein gp120 re...
The high affinity binding site for human immunodeficiency virus (HIV) envelope glycoprotein gp120 re...
Human immunodeficiency virus (HIV-1) enters target cells by binding its gp120 exterior envelope glyc...
We have used cells infected with the HIV-1 molecular clone HX10 to study the binding of monoclonal a...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
The entry of human immunodeficiency virus (HIV-1) into target cells typically requires the sequentia...
A subset of the neutralizing anti-HIV antibodies recognize epitopes on the envelope protein gp120 of...
AbstractUsing immunobiochemical approaches we previously studied the conformation and surface exposu...
AbstractHuman immunodeficiency virus (HIV-1) enters target cells by binding its gp120 exterior envel...
AbstractUsing immunobiochemical approaches we previously studied the conformation and surface exposu...
Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by exper...
AbstractThe binding of antibodies to the CD4-binding site (CD4bs) of the HIV-1 envelope glycoprotein...
Broadly neutralizing antibodies are not commonly produced in HIV-1 infected individuals nor by exper...
The high affinity binding site for human immunodeficiency virus (HIV) envelope glycoprotein gp120 re...
The high affinity binding site for human immunodeficiency virus (HIV) envelope glycoprotein gp120 re...
Human immunodeficiency virus (HIV-1) enters target cells by binding its gp120 exterior envelope glyc...